Omeros
Yahoo Finance • 2 months ago
Omeros earnings beat by $0.03, revenue topped estimates
Investing.com - Omeros (NASDAQ: OMER) reported second quarter EPS of $-0.430, $0.03 better than the analyst estimate of $-0.460. Revenue for the quarter came in at $28.6M versus the consensus estimate of $416.67K. Omeros’s stock price clo... Full story
Yahoo Finance • 2 months ago
Earnings call transcript: Omeros beats Q2 2025 EPS forecast, stock dips
Omeros Corporation reported a better-than-expected earnings per share (EPS) for Q2 2025, with a net loss of $0.43 per share, beating the forecasted loss of $0.46. Despite this positive surprise, the company’s stock fell by 0.7% in aftermar... Full story
Yahoo Finance • 3 months ago
Omeros Secures $22 Mln In Registered Direct Offering With Polar Asset Management
(RTTNews) - Omeros Corporation (OMER) entered into a securities purchase agreement with Polar Asset Management Partners to raise approximately $22 million through a registered direct offering on Thursday. The agreement includes the sale o... Full story
Yahoo Finance • 2 years ago
Omeros Corporation to Announce Third Quarter Financial Results on November 9, 2023
SEATTLE, November 06, 2023--(BUSINESS WIRE)--Omeros Corporation (NASDAQ: OMER), today announced that the company will issue its financial results for the quarter ended September 30, 2023, on Thursday, November 9, 2023, after the market clo... Full story
Yahoo Finance • 2 years ago
Omeros Announces Online Publication in Advance of ASH Annual Meeting Detailing Narsoplimab Treatment Under Compassionate Use of 15 Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic Microangiopathy
-- Poster Presentation Slated for Upcoming Annual Meeting of the American Society of Hematology -- SEATTLE, November 03, 2023--(BUSINESS WIRE)--Omeros Corporation (Nasdaq: OMER) today announced online publication of a report detailing tre... Full story
Yahoo Finance • 3 years ago
Why Omeros Stock Is Freefalling Today
After skyrocketing by above 68.7% on Friday with no clear catalyst to speak of, Omeros (NASDAQ: OMER) stock came crashing down to earth, losing more than 33% of its value as of 3:44 p.m. on Tuesday. Stock prices are important for biotech c... Full story
